Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Prevalence of Classic and Non-Classic Antiphospholipid Antibodies in Multiple Sclerosis.

Shor DB, Weiss GA, Barzilai O, Ram M, Anaya JM, Shoenfeld Y, Sherer Y.

Isr Med Assoc J. 2015 Sep;17(9):559-62.

2.

A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.

Yaniv G, Twig G, Shor DB, Furer A, Sherer Y, Mozes O, Komisar O, Slonimsky E, Klang E, Lotan E, Welt M, Marai I, Shina A, Amital H, Shoenfeld Y.

Autoimmun Rev. 2015 Jan;14(1):75-9. Review.

PMID:
25449682
3.

Novel antiphospholipid antibodies in autoimmune bullous diseases.

Sagi L, Baum S, Barzilai O, Ram M, Bizzaro N, SanMarco M, Shoenfeld Y, Sherer Y.

Hum Antibodies. 2014;23(1-2):27-30. doi: 10.3233/HAB-140280.

PMID:
25812700
4.

Early operative intervention is associated with better patient survival in patients with intracapsular femur fractures but not extracapsular fractures.

Steinberg EL, Sternheim A, Kadar A, Sagi Y, Sherer Y, Chechik O.

J Arthroplasty. 2014 May;29(5):1072-5. doi: 10.1016/j.arth.2013.10.021. Epub 2013 Oct 26.

PMID:
24290967
5.

Scientific evidence of the therapeutic effects of dead sea treatments: a systematic review.

Katz U, Shoenfeld Y, Zakin V, Sherer Y, Sukenik S.

Semin Arthritis Rheum. 2012 Oct;42(2):186-200. doi: 10.1016/j.semarthrit.2012.02.006. Epub 2012 Apr 12. Review.

PMID:
22503590
6.

Determining the relationship between tree-stem respiration and CO2 efflux by δO2/Ar measurements.

Angert A, Sherer Y.

Rapid Commun Mass Spectrom. 2011 Jun 30;25(12):1752-6. doi: 10.1002/rcm.5042.

PMID:
21598335
7.

Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature.

Sagi L, Baum S, Agmon-Levin N, Sherer Y, Katz BS, Barzilai O, Ram M, Bizzaro N, SanMarco M, Trau H, Shoenfeld Y.

Autoimmun Rev. 2011 Jul;10(9):527-35. doi: 10.1016/j.autrev.2011.04.003. Epub 2011 Apr 16. Review.

PMID:
21527361
8.

Atherosclerosis in systemic lupus erythematosus.

Sherer Y, Zinger H, Shoenfeld Y.

Autoimmunity. 2010 Feb;43(1):98-102. doi: 10.3109/08916930903374527. Review.

PMID:
20014976
9.

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.

Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, Cervera R, Doria A, Jayne D, Khamashta MA, Kuhn A, Gordon C, Petri M, Rekvig OP, Schneider M, Sherer Y, Shoenfeld Y, Smolen JS, Talarico R, Tincani A, van Vollenhoven RF, Ward MM, Werth VP, Carmona L.

Ann Rheum Dis. 2010 Jul;69(7):1269-74. doi: 10.1136/ard.2009.117200. Epub 2009 Nov 5.

10.

Common infectious agents prevalence in antiphospholipid syndrome.

Zinger H, Sherer Y, Goddard G, Berkun Y, Barzilai O, Agmon-Levin N, Ram M, Blank M, Tincani A, Rozman B, Cervera R, Shoenfeld Y.

Lupus. 2009 Nov;18(13):1149-53. doi: 10.1177/0961203309345738.

PMID:
19880561
11.

Infectious antibodies in systemic lupus erythematosus patients.

Berkun Y, Zandman-Goddard G, Barzilai O, Boaz M, Sherer Y, Larida B, Blank M, Anaya JM, Shoenfeld Y.

Lupus. 2009 Nov;18(13):1129-35. doi: 10.1177/0961203309345729.

PMID:
19880558
12.

Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease.

Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Blank M, Ram M, Sherer Y, Anaya JM, Shoenfeld Y.

Ann N Y Acad Sci. 2009 Sep;1173:658-63. doi: 10.1111/j.1749-6632.2009.04754.x.

PMID:
19758212
13.

Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.

Zinger H, Sherer Y, Shoenfeld Y.

Clin Rev Allergy Immunol. 2009 Aug;37(1):20-8. doi: 10.1007/s12016-008-8094-x. Review.

PMID:
18991025
14.

Pemphigus and infectious agents.

Sagi L, Sherer Y, Trau H, Shoenfeld Y.

Autoimmun Rev. 2008 Oct;8(1):33-5. doi: 10.1016/j.autrev.2008.07.021. Epub 2008 Aug 14. Review.

PMID:
18707028
15.

Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology.

Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y, Shoenfeld Y.

Autoimmun Rev. 2008 Dec;8(2):112-5. doi: 10.1016/j.autrev.2008.07.013.

PMID:
18700170
16.

Bacterial triggers and autoimmune rheumatic diseases.

Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A.

Clin Exp Rheumatol. 2008 Jan-Feb;26(1 Suppl 48):S12-7. Review.

PMID:
18570749
17.

Carotid artery intima-media thickness, heat shock proteins and oxidized LDL autoantibodies in systemic necrotizing vasculitis.

Sherer Y, Pagnoux C, Chironi G, Simon A, Guillevin L, Mouthon L, Gilburd B, Shoenfeld Y.

Rheumatol Int. 2008 Sep;28(11):1099-103. doi: 10.1007/s00296-008-0587-7. Epub 2008 Apr 29.

PMID:
18443794
18.

Issues in rheumatology and autoimmunity. Preface.

Sherer Y.

Isr Med Assoc J. 2008 Feb;10(2):138. No abstract available.

19.

Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis.

Gerli R, Bartoloni Bocci E, Sherer Y, Vaudo G, Moscatelli S, Shoenfeld Y.

Ann Rheum Dis. 2008 May;67(5):724-5. doi: 10.1136/ard.2007.073718. No abstract available.

PMID:
18408112
20.

Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease.

Marai I, Shechter M, Langevitz P, Gilburd B, Rubenstein A, Matssura E, Sherer Y, Shoenfeld Y.

Am J Cardiol. 2008 Apr 15;101(8):1094-7. doi: 10.1016/j.amjcard.2007.12.010. Epub 2008 Feb 7.

PMID:
18394439
21.

A latitudinal gradient study of common anti-infectious agent antibody prevalence in Italy and Colombia.

Pordeus V, Barzilai O, Sherer Y, Luiz RR, Blank M, Bizzaro N, Villalta D, Anaya JM, Shoenfeld Y.

Isr Med Assoc J. 2008 Jan;10(1):65-8.

22.

Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.

Sherer Y, Kuechler S, Jose Scali J, Rovensky J, Levy Y, Zandman-Goddard G, Shoenfeld Y.

Isr Med Assoc J. 2008 Jan;10(1):55-7.

23.

The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.

Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Bizzaro N, Gilburd B, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Mackay IR, Orbach H, Ram M, Sherer Y, Toubi E, Gershwin ME.

Isr Med Assoc J. 2008 Jan;10(1):13-9. Review. No abstract available.

24.

The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008.

Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, de Carvalho JF, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y.

Isr Med Assoc J. 2008 Jan;10(1):8-12. Review. No abstract available.

25.

The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008.

Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Blank M, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Levy Y, Orbach H, Pordeus V, Ram M, Sherer Y, Toubi E, Tomer Y.

Isr Med Assoc J. 2008 Jan;10(1):3-7. Review. No abstract available.

26.

Cutting edge issues in autoimmunity.

Sherer Y, Matthias T, Shoenfeld Y.

Clin Rev Allergy Immunol. 2008 Jun;34(3):275-8. doi: 10.1007/s12016-007-8047-9. No abstract available.

PMID:
18172781
27.

Autoantibody explosion in antiphospholipid syndrome.

Shoenfeld Y, Twig G, Katz U, Sherer Y.

J Autoimmun. 2008 Feb-Mar;30(1-2):74-83. doi: 10.1016/j.jaut.2007.11.011. Epub 2008 Jan 2.

PMID:
18171610
28.

Antiphospholipid syndrome (APS): where does it come from?

Sherer Y, Blank M, Shoenfeld Y.

Best Pract Res Clin Rheumatol. 2007 Dec;21(6):1071-8. Review.

PMID:
18068862
29.

The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis.

Freire de Carvalho J, Sherer Y, Shoenfeld Y.

Thromb Haemost. 2007 Dec;98(6):1157-9. Review.

PMID:
18064307
30.

Tobacco smoking and autoimmune rheumatic diseases.

Harel-Meir M, Sherer Y, Shoenfeld Y.

Nat Clin Pract Rheumatol. 2007 Dec;3(12):707-15. Review.

PMID:
18037930
31.

Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report.

Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y.

Ann N Y Acad Sci. 2007 Jun;1108:567-77.

PMID:
17894021
32.

Heat-shock protein 65 autoantibodies are differently associated with early atherosclerosis in rheumatoid arthritis and in healthy subjects.

Sherer Y, Gerli R, Bocci EB, Gilburd B, Vaudo G, Bistoni O, Shoenfeld Y.

Ann N Y Acad Sci. 2007 Jun;1108:408-13.

PMID:
17894004
33.

Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors.

Gerli R, Sherer Y, Bocci EB, Vaudo G, Moscatelli S, Shoenfeld Y.

Ann N Y Acad Sci. 2007 Jun;1108:372-81. Review.

PMID:
17894000
34.

Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis.

Sherer Y, Cerinic MM, Bartoli F, Blagojevic J, Conforti ML, Gilburd B, Ehrenfeld M, Shoenfeld Y.

Ann N Y Acad Sci. 2007 Jun;1108:259-67.

PMID:
17893991
35.

Physical examination and ECG screening in relation to echocardiography findings in young healthy adults.

Landau DA, Grossman A, Sherer Y, Harpaz D, Azaria B, Carter D, Barenboim E, Goldstein L.

Cardiology. 2008;109(3):202-7. Epub 2007 Aug 27.

PMID:
17726322
36.

Hyponatremia induced by amiodarone therapy.

Shavit E, Sherer Y.

Isr Med Assoc J. 2007 Jul;9(7):564-5. No abstract available.

37.

The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease.

Shechter M, Marai I, Marai S, Sherer Y, Sela BA, Feinberg MS, Rubinstein A, Shoenfeld Y.

Isr Med Assoc J. 2007 Apr;9(4):271-6.

38.

Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies.

Sherer Y, Gerli R, Gilburd B, Bartoloni Bocci E, Vaudo G, Mannarino E, Shoenfeld Y.

Lupus. 2007;16(4):259-64.

PMID:
17439932
39.

Outcome of patients having dermatomyositis admitted to the intensive care unit.

Sherer Y, Shepshelovich D, Shalev T, Haviv Y, Segal E, Ehrenfeld M, Levy Y, Pauzner R, Shoenfeld Y, Langevitz P.

Clin Rheumatol. 2007 Nov;26(11):1851-5. Epub 2007 Feb 27.

PMID:
17332975
40.

Safety of intravenous immunoglobulin (IVIG) therapy.

Katz U, Achiron A, Sherer Y, Shoenfeld Y.

Autoimmun Rev. 2007 Mar;6(4):257-9. Epub 2006 Aug 28. Review.

PMID:
17317619
41.

Mechanisms of disease: atherosclerosis in autoimmune diseases.

Sherer Y, Shoenfeld Y.

Nat Clin Pract Rheumatol. 2006 Feb;2(2):99-106. Review.

PMID:
16932663
42.

Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.

Shovman O, Gilburd B, Zandman-Goddard G, Sherer Y, Shoenfeld Y.

Curr Rheumatol Rep. 2006 Aug;8(4):292-8. Review.

PMID:
16839508
43.

Matrix metalloproteinase-9 and autoimmune diseases.

Ram M, Sherer Y, Shoenfeld Y.

J Clin Immunol. 2006 Jul;26(4):299-307. Epub 2006 May 2. Review.

PMID:
16652230
44.

Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".

Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Cervera R, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, DCruz D, Depresseux G, Direskeneli H, Domènech I, Espinosa G, Fernández-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, Garcìa-Carrasco M, García Iglesias MF, García-Tobaruela A, George J, Gil A, González-Santos P, Grana M, Gül A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M, Jedryka-Góral A, Khamashta MA, Lavilla P, Levi Y, López-Dulpa M, López-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perelló I, Petera P, Petrovic R, Piette JC, Pintado V, de Pita O, Popovic R, Pucci G, Puddu P, de Ramón E, Ramos-Casals M, Rodríguez-Andreu J, Ruiz-Irastorza G, Sanchez-Lora J, Sanna G, Scorza R, Sebastiani GD, Sherer Y, Shoenfeld Y, Simpatico A, Sinico RA, Smolen J, Tincani A, Tokgöz G, Urbano-Márquez A, Vasconcelos C, Vázquez JJ, Veronesi J, Vianna J, Vivancos J; European Working Party on Systemic Lupus Erythematosus.

Autoimmun Rev. 2006 Mar;5(3):180-6. Epub 2005 Jul 26. Review.

PMID:
16483917
45.

Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.

Sherer Y, Shoenfeld Y.

Autoimmun Rev. 2006 Feb;5(2):153-5. Epub 2005 Sep 19. Review.

PMID:
16431350
46.

Intravenous immunoglobulin: adverse effects and safe administration.

Orbach H, Katz U, Sherer Y, Shoenfeld Y.

Clin Rev Allergy Immunol. 2005 Dec;29(3):173-84. Review.

PMID:
16391392
47.

Low levels of heat shock proteins-60 and -65 autoantibodies in Sjögren's syndrome.

Shovman O, Sherer Y, Gilbourd B, Gerli R, Bocci EB, delle Monache F, Luccioli F, Shoenfeld Y.

Isr Med Assoc J. 2005 Dec;7(12):778-80.

48.

[Indications--intravenous immunoglobulins--IVIG].

Etzioni A, Sherer Y, Carp H, Mimouni D, Achiron A, Goddard G, Catz U, Shoenfeld Y.

Harefuah. 2005 Nov;144(11):799-804. Review. Hebrew. No abstract available.

PMID:
16358657
49.

The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity.

Harel M, Aron-Maor A, Sherer Y, Blank M, Shoenfeld Y.

Immunobiology. 2005;210(10):743-7. Epub 2005 Oct 21. Review.

PMID:
16325492
50.

Accelerated atherosclerosis in autoimmune rheumatic diseases.

Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, Jara LJ, Abu-Shakra M, Meroni PL, Sherer Y.

Circulation. 2005 Nov 22;112(21):3337-47. Review. No abstract available.

PMID:
16301360

Supplemental Content

Loading ...
Support Center